Denis Lacombe

发表

Toward a Tiered Model to Share Clinical Trial Data and Samples in Precision Oncology

Michiel Verlinden, Isabelle Huys, Stefanie Broes, 2018, Front. Med..

Passive component embedding in printed circuit boards for space applications

Maarten Cauwe, Johan De Baets, Denis Lacombe, 2016 .

Improvement of the Wire Rating Standards based on TV Testing and Thermal Modeling

Denis Lacombe, Marc Malagoli, Roel van Benthem, 2018 .

All the World's a Stage: Facilitating Discovery Science and Improved Cancer Care through the Global Alliance for Genomics and Health.

Gil Alterovitz, Bin Tean Teh, Mark Lawler, 2015, Cancer discovery.

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial.

Denis Lacombe, Wolfgang Grisold, M. J. van den Bent, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Using the continual reassessment method: lessons learned from an EORTC phase I dose finding study.

Xavier Paoletti, Richard Sylvester, Patrick Schöffski, 2006, European journal of cancer.

Defining dose-limiting toxicity for phase 1 trials of molecularly targeted agents: results of a DLT-TARGETT international survey.

Percy Ivy, Xavier Paoletti, Laurence Collette, 2014, European journal of cancer.

Individual patient data analysis to assess modifications to the RECIST criteria.

Robert Ford, Larry Rubinstein, Elizabeth Eisenhauer, 2009, European journal of cancer.

EORTC Radiation Oncology Group quality assurance platform: establishment of a digital central review facility.

Damien C Weber, Vincent Gregoire, Akos Gulyban, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Phase II study of imatinib in patients with recurrent gliomas of various histologies: a European Organisation for Research and Treatment of Cancer Brain Tumor Group Study.

Denis Lacombe, Johan M Kros, R. Stupp, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The dream and reality of histology agnostic cancer clinical trials

Denis Lacombe, Jan Bogaerts, Vassilis Golfinopoulos, 2014, Molecular oncology.

European perspective for effective cancer drug development

Sabine Tejpar, Denis Lacombe, Daniela Aust, 2014, Nature Reviews Clinical Oncology.

Sharing human samples and patient data: Opening Pandora’s box

Michiel Verlinden, Isabelle Huys, Stefanie Broes, 2017 .

The European Organisation for Research and Treatment of Cancer, State of Science in radiation oncology and priorities for clinical trials meeting report.

Matthias Guckenberger, Cai Grau, Damien C. Weber, 2020, European journal of cancer.

Steps forward for cancer precision medicine

Sabine Tejpar, Jeffrey A. Moscow, John W. M. Martens, 2018, Nature Reviews Drug Discovery.

How can innovative forms of clinical research contribute to deliver affordable cancer care in an evolving health care environment?

Françoise Meunier, Denis Lacombe, D. Lacombe, 2013, European journal of cancer.

Glufosfamide: can we improve the process of anticancer agent development?

Denis Lacombe, D. Lacombe, 2012, Expert opinion on investigational drugs.

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma

Brigitta G. Baumert, Jaap C. Reijneveld, Andreas von Deimling, 2016, The Lancet. Oncology.

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

Winand N M Dinjens, Jean-Yves Delattre, Denis Lacombe, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

Pieter Wesseling, Hendrikus J Dubbink, Winand N M Dinjens, 2010, Clinical Cancer Research.

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

Elizabeth Eisenhauer, Denis Lacombe, Michael Weller, 2008, The Lancet. Oncology.